Impact of preoperative antithrombotic therapy in patients undergoing elective isolated coronary artery bypass grafting.

ABSTRACT:

Objectives

The objective of this retrospective study was to assess differences in clinical outcomes between patients on acetylsalicylic acid (ASA) monotherapy and patients on other antithrombotic (AT) regimens undergoing elective coronary artery bypass grafting (CABG).

Methods

Patients who underwent elective isolated CABG between 2017 and 2019 at the Catharina Hospital Eindhoven were eligible for this study. The primary end points were re-exploration for bleeding and postoperative blood product transfusion. Secondary end points included 30-day mortality, in-hospital stroke, in-hospital myocardial infarction and duration of hospitalization. Propensity matching was used to compare outcomes of the main study groups (ASA vs other AT therapy) and subgroups of AT therapy (guidelin

SUBMITTER: van Steenbergen GJ 

PROVIDER: S-EPMC8691704 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature